However, to date, anti-cancer activities of EGF-NPs have only been investigated using gold NPs as EGF carriers, as it is easy to control their diameter, shape, and surface functionalities for the fundamental analysis of their impacts on cellular cytotoxicity and intracellular signaling [17]. The gene discussed is EGF; the disease is cancer.